Tg Therapeutics (TGTX) Short-term Investments (2014 - 2026)

Tg Therapeutics' Short-term Investments history runs 13 years deep, the most recent figure standing at $72.2 million for Q1 2026.

• In Q1 2026, Short-term Investments fell 49.88% year-over-year to $72.2 million; the TTM figure through Mar 2026 stood at $72.2 million (down 49.88% YoY), while the FY2025 annual figure was $62.8 million, down 52.08% from the prior year.
• Short-term Investments was $72.2 million for Q1 2026 at Tg Therapeutics, up from $62.8 million in the prior quarter.
• In the past five years, Short-term Investments ranged from a high of $145.2 million in Q3 2024 to a low of $47.5 million in Q1 2022.
• Historically, Short-term Investments has averaged $91.5 million across 5 years, with a median of $78.2 million in 2023.
• The sharpest annual moves came in 2022 and 2025: Short-term Investments jumped 273.99% in 2022, then tumbled 60.4% in 2025.
• A 5-year view of Short-term Investments shows it stood at $59.4 million in 2022, then soared by 109.81% to $124.6 million in 2023, then rose by 5.24% to $131.1 million in 2024, then slumped by 52.08% to $62.8 million in 2025, then climbed by 14.96% to $72.2 million in 2026.
• The last three Short-term Investments figures came in at $72.2 million (Q1 2026), $62.8 million (Q4 2025), and $57.5 million (Q3 2025), per Business Quant data.